Personal Digest: FDA OKs IDE for NeuWire's STROKE-REWIRE Trial
Digest Newsletter
·
Oct 7, 2026
Personal Digest: FDA OKs IDE for NeuWire's STROKE-REWIRE Trial
Welcome to Matters.com™ beta, where the world shows what matters. More information? Click here.
FDA approved IDE — The FDA granted an Investigational Device Exemption enabling NeuWire Medical's STROKE-REWIRE trial of vagus nerve stimulation for chronic ischemic stroke.
 | vagus nerve stimulationNew open-source platform brings nerve stimulation modeling to the masses · bioengineer.org |
Top Moments
!NeuWireReWireFDAApproval
FDA approved IDE for NeuWire Medical's STROKE-REWIRE trial of vagus nerve stimulation for chronic ischemic stroke
!VNSMyelinRepairStudy
CU Anschutz researchers found vagus nerve stimulation improves myelin repair in MS patients
!OHSUVagusNerveStimulationImplant
OHSU neurosurgeons implanted vagus nerve stimulation devices for stroke and arthritis recovery